Search research articles
Contact Us
Filters
Showing results (281-290 of 449) with videos related to
Page
of 45
Sort By:
ACS Nano
|
April 19, 2018
General Synthetic Strategy for Libraries of Supported Multicomponent Metal Nanoparticles
Hui Yang, Siobhan J Bradley, Xin Wu, et al.
Journal of Hepatology
|
February 15, 2003
Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression
Nathalie Wong, Andrew Chan, Siu-Wah Lee, et al.
Expert Review of Clinical Immunology
|
September 11, 2023
Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation
Uwe Klaus Zettl, Paulus Stefan Rommer, Orhan Aktas, et al.
Blood
|
January 5, 2011
Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system
Alexander Baraniskin, Jan Kuhnhenn, Uwe Schlegel, et al.
Scientific Reports
|
January 14, 2021
Simultaneous lesion and brain segmentation in multiple sclerosis using deep neural networks
Richard McKinley, Rik Wepfer, Fabian Aschwanden, et al.
Journal of Central Nervous System Disease
|
May 7, 2024
Different lymphocyte counts of multiple sclerosis patients treated with ofatumumab and ocrelizumab: A retrospective observational study
Christoph Friedli, Nik Krajnc, Helly N Hammer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 8, 2016
Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy
Robert Hoepner, Eva M Kolb, Stefanie Dahlhaus, et al.
Acta Neuropathologica Communications
|
June 18, 2026
Higher disease reactivation risk in women after fingolimod withdrawal
Marine Massy, Stefanie Marti, Adriane Kutllovci, et al.
Multiple Sclerosis and Related Disorders
|
December 11, 2024
Disability progression is a question of definition-A methodological reappraisal by example of primary progressive multiple sclerosis
Gabriel Bsteh, Stefanie Marti, Nik Krajnc, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 20, 2021
Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses
Brian T Wipke, Robert Hoepner, Katrin Strassburger-Krogias, et al.
Page
of 45
Search research articles
Search
Showing results (281-290 of 449) with videos related to
Sort By:
Page
of 45
ACS Nano
|
April 19, 2018
General Synthetic Strategy for Libraries of Supported Multicomponent Metal Nanoparticles
Hui Yang, Siobhan J Bradley, Xin Wu, et al.
Journal of Hepatology
|
February 15, 2003
Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression
Nathalie Wong, Andrew Chan, Siu-Wah Lee, et al.
Expert Review of Clinical Immunology
|
September 11, 2023
Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation
Uwe Klaus Zettl, Paulus Stefan Rommer, Orhan Aktas, et al.
Blood
|
January 5, 2011
Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system
Alexander Baraniskin, Jan Kuhnhenn, Uwe Schlegel, et al.
Scientific Reports
|
January 14, 2021
Simultaneous lesion and brain segmentation in multiple sclerosis using deep neural networks
Richard McKinley, Rik Wepfer, Fabian Aschwanden, et al.
Journal of Central Nervous System Disease
|
May 7, 2024
Different lymphocyte counts of multiple sclerosis patients treated with ofatumumab and ocrelizumab: A retrospective observational study
Christoph Friedli, Nik Krajnc, Helly N Hammer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 8, 2016
Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy
Robert Hoepner, Eva M Kolb, Stefanie Dahlhaus, et al.
Acta Neuropathologica Communications
|
June 18, 2026
Higher disease reactivation risk in women after fingolimod withdrawal
Marine Massy, Stefanie Marti, Adriane Kutllovci, et al.
Multiple Sclerosis and Related Disorders
|
December 11, 2024
Disability progression is a question of definition-A methodological reappraisal by example of primary progressive multiple sclerosis
Gabriel Bsteh, Stefanie Marti, Nik Krajnc, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 20, 2021
Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses
Brian T Wipke, Robert Hoepner, Katrin Strassburger-Krogias, et al.
Page
of 45